INSTANT>COFFEE>MIXTURE>WITH>TONGKAT>ALI POWDER

Indications

• Mental alertness enhancement
• Cognitive performance improvement
• Temporary relief of fatigue

Dosage

Children: Caffeine use in children and adolescents should be approached with caution. It is advisable to refer to specific guidelines and consult a healthcare provider for appropriate dosing.

Adults: General guidance suggests that moderate caffeine intake of 200-400 mg per day is considered safe for most adults, but individual tolerance may vary.

Mechanism of action

Caffeine works primarily by antagonizing adenosine receptors, specifically A1 and A2A subtypes. By blocking these receptors, caffeine inhibits the inhibitory effects of adenosine, leading to increased neuronal firing and the release of neurotransmitters such as dopamine and norepinephrine. This results in enhanced alertness, reduced perception of fatigue, and improved mood.

Pharmacodynamics

Caffeine exhibits dose-dependent effects on the central nervous system. At lower doses, it primarily promotes alertness and cognitive function, while at higher doses it can lead to increased heart rate and blood pressure. The stimulating effects of caffeine typically peak within 1-2 hours after consumption and can last for several hours, depending on individual sensitivity and metabolism.

Pharmacokinetics

Caffeine is rapidly absorbed from the gastrointestinal tract, with peak plasma concentrations occurring within 1-2 hours of ingestion. It is metabolized primarily in the liver by cytochrome P450 enzymes, mainly CYP1A2, into paraxanthine, theobromine, and theophylline, which have various pharmacological effects. The elimination half-life of caffeine varies widely among individuals, typically ranging from 3 to 7 hours, and can be affected by factors such as age, liver function, pregnancy, and concurrent medications.

Adverse effects

• Insomnia
• Nervousness
• Restlessness
• Stomach upset
• Nausea
• Increased heart rate
• Headaches
• Dizziness

Interactions

• May enhance the effects of certain stimulants
• May interact with medications that affect blood pressure
• Caution with anticoagulants due to potential increased risk of bleeding

Precautions

• Use cautiously in patients with anxiety disorders
• Use cautiously in patients with cardiac conditions
• Avoid excessive consumption to prevent adverse effects

Pregnancy

Caffeine intake should be limited during pregnancy due to potential risks of miscarriage and low birth weight.

Breast-feeding

Caffeine is excreted in breast milk; moderate consumption is generally considered safe, but excessive intake should be avoided.

Storage

Store in a cool, dry place away from light and moisture.

Formulations

• Coffee beans
• Ground coffee
• Instant coffee
• Coffee extracts

Indications

• Ethanol intoxication
• Detoxification in alcohol dependence
• Antiseptic and disinfectant
• Solvent in pharmaceutical preparations

Dosage

Children: Refer to BNF for Children for appropriate dosing information.

Adults: Refer to BNF for specific dosing information based on clinical indications.

Mechanism of action

Ethanol affects the brain’s neurons by altering their membranes, ion channels, enzymes, and receptors. It binds directly to GABA, glycine, NMDA, acetylcholine, and serotonin receptors, enhancing the inhibitory effects of GABA at GABAa receptors and blocking NMDA receptors for glutamate. This results in reduced excitatory neurotransmission, contributing to its sedative effects. Ethanol also acts as a dehydrating agent, disrupting osmotic balance across cell membranes, which enhances its anti-infective properties.

Pharmacodynamics

Ethanol produces cytotoxic effects through dehydration and precipitation of cellular components, leading to bacteriocidal and antifungal actions. It is metabolized primarily in the liver by alcohol dehydrogenase, with 90 to 98% of ethanol oxidized to acetaldehyde and further to acetic acid. The interaction of ethanol with various neurotransmitter receptors modulates neuronal signaling, which is responsible for its psychoactive effects. Chronic exposure leads to tolerance, characterized by adaptive changes in neurotransmitter systems.

Pharmacokinetics

Ethanol is rapidly absorbed from the gastrointestinal tract, with peak blood concentrations occurring approximately 30 to 90 minutes after consumption. It is distributed throughout body water, with a volume of distribution that varies based on fat and water content in the body. Ethanol is primarily metabolized in the liver, with a small fraction excreted unchanged in urine and breath. The elimination half-life can vary significantly based on individual metabolic rates and liver function.

Contra-indications

• Hypersensitivity to ethanol or any of its components
• Severe liver disease
• Active gastrointestinal bleeding
• Acute pancreatitis

Adverse effects

• Drowsiness
• Dizziness
• Nausea
• Vomiting
• Headache
• Impaired coordination
• Dependence and withdrawal symptoms with chronic use

Interactions

• Increased sedation with other CNS depressants (e.g., benzodiazepines, opioids)
• Inhibition of the metabolism of drugs metabolized by CYP2E1
• Potentially increased risk of gastrointestinal bleeding with nonsteroidal anti-inflammatory drugs (NSAIDs)
• May enhance the hypoglycemic effect of antidiabetic medications

Precautions

• Use with caution in patients with a history of alcohol use disorder
• Monitor for signs of liver function impairment
• Avoid use in pregnant women due to potential fetal harm
• Caution in patients with a history of seizure disorders

Pregnancy

Ethanol should be avoided during pregnancy due to the risk of fetal alcohol spectrum disorders.

Breast-feeding

Ethanol is excreted in breast milk; mothers should avoid alcohol consumption during breastfeeding.

Storage

Store in a cool, dry place away from light and tightly closed in its original container.

Formulations

• Oral solutions
• Topical antiseptic solutions
• Medicated syrups

Indications

• Pain management
• Inflammation control
• Symptomatic relief in various conditions

Dosage

Children: Refer to specific product guidelines for dosing information.

Adults: Refer to specific product guidelines for dosing information.

Mechanism of action

The individual components of Mixturewith may exert their effects through various mechanisms. Analgesics typically work by inhibiting the synthesis of prostaglandins, which are responsible for pain and inflammation. Anti-inflammatory agents may modulate immune responses and suppress the production of inflammatory mediators. The combination aims to provide comprehensive relief by targeting multiple pathways involved in pain and inflammation.

Pharmacodynamics

The pharmacodynamics of Mixturewith depend on its active ingredients. Analgesics generally reduce pain perception by acting on central and peripheral nervous systems. Anti-inflammatory components decrease swelling and inflammation, improving overall function and comfort. The combination enhances the therapeutic effects while potentially reducing the required doses of each ingredient, thus minimizing side effects.

Pharmacokinetics

The pharmacokinetics of Mixturewith will vary based on its specific formulation. Generally, the absorption of the active ingredients occurs in the gastrointestinal tract, with peak plasma concentrations typically achieved within hours after ingestion. Distribution occurs throughout the body, with varying protein binding characteristics among different components. Metabolism usually takes place in the liver, and elimination occurs primarily through renal pathways, with half-lives differing significantly depending on the active substances present.

Indications

• Low testosterone levels
• Erectile dysfunction
• Libido enhancement
• Athletic performance enhancement
• Fatigue and energy support

Dosage

Children: There is insufficient evidence to support the use of tongkat in children, and it is not generally recommended.

Adults: Refer to product-specific guidelines, as there is no standardized adult dosage.

Mechanism of action

Tongkat is believed to exert its effects primarily through the inhibition of sex hormone-binding globulin (SHBG), which increases the bioavailability of testosterone. It may also influence the hypothalamic-pituitary-gonadal (HPG) axis, promoting the release of luteinizing hormone (LH) and testosterone from the testes. Additionally, it may have adaptogenic properties, helping the body resist stress and improve physical performance.

Pharmacodynamics

The pharmacodynamics of tongkat involves its influence on hormone levels, particularly testosterone. By reducing SHBG levels, tongkat increases free testosterone, which is more biologically active and can enhance various physiological functions. It may also improve the body's response to stress and promote an increase in muscle strength and mass.

Pharmacokinetics

The pharmacokinetics of tongkat is not extensively studied, but it is generally considered to be well-absorbed when taken orally. Its active compounds may undergo metabolism in the liver, and the elimination half-life is not well defined. More research is needed to fully understand the absorption, distribution, metabolism, and excretion of tongkat's constituents.

Adverse effects

• Insomnia
• Irritability
• Increased heart rate
• Anxiety
• Restlessness

Precautions

• Individuals with heart conditions should use with caution.
• Use with caution in patients with anxiety disorders.

Pregnancy

Insufficient evidence is available regarding the safety of tongkat use during pregnancy; caution is advised.

Breast-feeding

There is limited information on the excretion of tongkat in breast milk; caution is recommended.

Storage

Store in a cool, dry place away from direct sunlight. Keep out of reach of children.

Formulations

• Powder
• Capsules
• Extracts

Mechanism of action

Ethanol affects the brain’s neurons in several ways. It alters their membranes as well as their ion channels, enzymes, and receptors. Alcohol also binds directly to the receptors for acetylcholine, serotonin, GABA, and the NMDA receptors for glutamate. The sedative effects of ethanol are mediated through binding to GABA receptors and glycine receptors (alpha 1 and alpha 2 subunits). It also inhibits NMDA receptor functioning. In its role as an anti-infective, ethanol acts as an osmolyte or dehydrating agent that disrupts the osmotic balance across cell membranes. ... Ethanol is known to affect a large number of membrane proteins that participate in signaling pathways such as neurotransmitter receptors, enzymes, and ion channels, and there is extensive evidence that ethanol interacts with a variety of neurotransmitters. The major actions of ethanol involve enhancing the inhibitory effects of gamma-aminobutyric acid (GABA) at GABAa receptors and blockade of the N-methyl-D-aspartate (NMDA) subtype of glutamate, an excitatory amine acid (EAA) receptor. Animal studies indicate that the acute effects of ethanol result from competitive inhibition of glycine binding to NMDA receptor and disruption of glutamatergic neurotransmission by inhibiting the response of the NMDA receptor. Persistent glycine antagonism and attenuation of glutamatergic neurotransmission by chronic ethanol exposure results in tolerance to ethanol by enhancing EAA neurotransmission and NMDA receptor upregulation. The latter appears to involve selective increases in NMDA R2B subunit concentrations and other molecular changes in specific brain loci. The abrupt withdrawal of ethanol thus produces a hyperexcitable state that leads to the ethanol withdrawal syndrome and excitotoxic neuronal death. GABA-mediated inhibition, which normally acts to limit excitation, is eliminated during ethanol withdrawal syndrome and further intensifies this excitation. In addition, NMDA receptors function to inhibit the release of dopamine in the nucleus accumbens and mesolimbic structures, which modulate the reinforcing action of addictive xenobiotics such as ethanol. By inhibiting NMDA receptor activity, ethanol could increase dopamine release from the nucleus accumbens and ventral tegmental area and could thus create dependence. Chronic ethanol administration also results in tolerance, dependence, and an ethanol withdrawal syndrome, mediated, in part, by desensitization and or downregulation of GABAa receptors. The development of alcoholic ketoacidosis (AKA) requires that a combination of physical and physiologic events occur. The normal response to starvation and depletion of hepatic glycogen stores is for amino acids to be converted to pyruvate. Pyruvate can serve as a substrate for gluconeogenesis, be converted to acetyl-CoA, which can enter the Krebs cycle or can be utilized in various biosynthetic pathways (eg, fatty acid, ketone bodies, cholesterol, and acetylcholine) ... Ethanol metabolism generates NADH, resulting in an excess of reducing potential. This high redox state favors the conversion of pyruvate to lactate, diverting pyruvate from being a substrate for gluconeogenesis. To compensate for the lack of normal metabolic substrates, the body mobilizes fat from adipose tissue and increased fatty acid metabolism as an alternative source of energy. This response is mediated by a decrease in insulin and an increased secretion of glucagon, catecholamines, growth hormone, and cortisol. Fatty acid metabolism results in the formation of acetyl-CoA and it combines with the excess acetate that is generated from ethanol metabolism to form acetoacetate. Most of the acetoacetate is reduced to beta-hydroxybutyrate due to the excess reducing potential or high redox state of the cell. Volume depletion interferes with the renal elimination of acetoacetate and beta-hydroxybutyrate, and contributes to the acidosis. An elevated lactate concentration may result from shunting from pyruvate or

Pharmacodynamics

Alcohol produces injury to cells by dehydration and precipitation of the cytoplasm or protoplasm. This accounts for its bacteriocidal and antifungal action. When alcohol is injected in close proximity to nerve tissues, it produces neuritis and nerve degeneration (neurolysis). Ninety to 98% of ethanol that enters the body is completely oxidized. Ethanol is also used as a cosolvent to dissolve many insoluble drugs and to serve as a mild sedative in some medicinal formulations. Ethanol also binds to GABA, glycine, NMDA receptors and modulates their effects. Ethanol is also metabolised by the hepatic enzyme alcohol dehydrogenase.